Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International



Home > Press > Standard & Poor's Outlook for RUSNANO Revised To Stable On Strong Ongoing Support; Affirmed At 'BB+/B/ruAA+'

Abstract:
Standard & Poor's expects strong ongoing state support to be provided to Russian Corporation of Nanotechnologies (RUSNANO) in the next few years. The agency expects a "high" probability of extraordinary timely government support if necessary. Therefore the outlook on RUSNANO was revised to stable from negative and affirmed the 'BB+' long-term, 'B' short-term, and 'ruAA+' national scale ratings on RUSNANO.

Standard & Poor's Outlook for RUSNANO Revised To Stable On Strong Ongoing Support; Affirmed At 'BB+/B/ruAA+'

Russia | Posted on May 14th, 2010

RUSNANO is a state investment institution established by the government of the Russian Federation (foreign currency BBB/Stable/A-3; local currency BBB+/Stable/A-2; Russia national scale 'ruAAA'). At the same time we affirmed our 'BB+' long-term and 'B' short-term issuer credit ratings and our 'ruAA+' Russia national scale rating on RUSNANO.

"The outlook revision reflects strong ongoing support expected from the Russian government at least until 2012 in the form of capital injections and guarantees until 2015," said Standard & Poor's credit analyst Boris Kopeykin.

S&P uses its criteria for government-related entities in rating RUSNANO. In spite of the recent government decision to change RUSNANO's legal status from a state corporation to a joint-stock company (in 2010-2011), we believe there is a "high" likelihood that it would receive timely, extraordinary support from the state in case of financial distress. Our opinion is based on the following:

Important role for the government of Russia. The government created RUSNANO to support state policies on promoting economic diversification into innovative sectors. The corporation is supposed to invest in projects that apply nanotechnology and promote such investments in the market. It is one of the main tools of economic diversification in high-tech industries now used by the government. RUSNANO selects and provides financing in the form of capital injections, loans, and guarantees to start-ups in the sector. The government has approved regular large equity injections for RUSNANO until 2012. The company's capital is likely to reach Russian ruble (RUB) 130 billion (almost $5 billion at that moment$)-?the equivalent of about 0.3% of Russia's GDP--by year-end 2012;
Very strong link with the Russian government, its full owner. RUSNANO will be transformed into a joint-stock company in 2010-2011, but privatization is not expected. The government is tightly monitoring RUSNANO, and several Russian ministers sit on the board. The government announced its plans to guarantee RUSNANO's expected bond issues of RUB182 billion in 2010-2015, including RUB53 billion in 2010. Politically it is a very visible entity.The stable outlook balances our expectations of a "high" probability of timely extraordinary support and currently strong ongoing support with the uncertainty regarding RUSNANO's relationship with the state in the longer term, and still further uncertainties about the viability of the applied business model.
"Confirmation of the government's strong ongoing support to the company, and of the availability of timely extraordinary support to the company in an emergency in the longer term, might result in an upgrade," said Mr. Kopeykin.

In contrast, a downgrade might result if S&P observes signs of weakening ongoing or lower chances of timely extraordinary support. Additional pressure might come from larger-than-expected borrowings, particularly borrowings with only up to three-year maturities, and deterioration of the liquidity position, which agency doesn't currently expect.

Source: Standard&Poor's

####

About RUSNANO
The Russian Corporation of Nanotechnologies (RUSNANO) was established in 2007 by the Federal law ¹ 139-FZ to enable Government policy in the field of Nanotechnology.

To accomplish this task, RUSNANO co-invests in nanotechnology industry projects that have high commercial potential or social benefit. Early-stage investment by RUSNANO lowers the risk of its investment partners from the private sector.

RUSNANO participates in building nanotechnology infrastructure, which includes the nanotechnology centers of excellence, business incubators and early stage investment funds. RUSNANO provides scientific and educational programs that are required for its investment projects to succeed, and also supports the popularization of nanoscience and nanotechnology. RUSNANO selects promising spheres for investment based on longer-term foresight created by the leading Russian and world experts.

To assist the Russian nanotechnology industry advance to the global market and strengthening of its international links RUSNANO develops partnerships with the leading nanotechnology centers in the world and organizes the annual Nanotechnology International Forum in Russia.

For more information, please click here

Copyright © RUSNANO

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024

Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024

Nanotechnology: Flexible biosensors with modular design November 8th, 2024

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

Announcements

Nanotechnology: Flexible biosensors with modular design November 8th, 2024

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

Turning up the signal November 8th, 2024

Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024

Financial Reports

180 Degree Capital Corp. Reports +14.2% Growth in Q1 2021, $10.60 Net Asset Value Per Share as of March 31, 2021, and Developments From Q2 2021 May 11th, 2021

Arrowhead Pharmaceuticals to Webcast Fiscal 2021 Second Quarter Results April 16th, 2021

Arrowhead Pharmaceuticals to Webcast Fiscal 2021 Second Quarter Results April 16th, 2021

180 Degree Capital Corp. Reports +6.7% Growth in Q4 2020, $9.28 Net Asset Value per Share as of December 31, 2020, and Developments from Q1 2021 Including Expected Investment in a Planned SPAC Sponsor February 22nd, 2021

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project